雌激素及其受体在胃肠道疾病中的作用(3)
4 总结及展望
临床中可以观察到多种胃肠道疾病的发生和预后存在性别差异,提示了雌激素或其受体在这些疾病中的作用,也为今后胃肠道疾病的治疗提供了潜在的治疗靶点。近年来,越来越多的证据表明,关于雌激素对非生殖器官的生理和病理生理的影响研究逐步深入,这些为提高胃肠道疾病的临床治疗提供重要的基础理论依据。但是仍然需要看到目前的研究仍以基础研究为主,对于雌激素治疗的具体机制仍未完全明确,雌激素及其受体在不同胃肠道疾病中的分子水平和作用机制的研究仍有待于进一步深入。同时转化医学的研究仍值得期待,与之相关的新型安全的治疗方案可能是今后的研发重点。
[1] Patel S, Homaei A, Raju AB, et al. Estrogen: The necessary evil for human health, and ways to tame it[J]. Biomed Pharmacother, 2018,102:403-411.
[2] Hess RA, Cooke PS. History of estrogen in the male: an historical perspective[J]. Biol Reprod, 2018,99(1):27-44.
[3] Nilsson S, Gustafsson JA. Estrogen receptors: Therapies targeted to receptor subtypes[J]. Clin Pharmacol Ther, 2011,89(1):44-55.
[4] Sharma G, Prossnitz ER. G-protein-coupled estrogen receptor (GPER) and sex-specific metabolic homeostasis[J]. Adv Exp Med Boil. 2017,1043:427-453.
[5] Kim YS, Kim N, Kim GH. Sex and gender differences in gastroesophageal reflux disease[J]. J Neurogastroenterol Motil, 2016,22(4):575-588.
[6] Boeckxstaens G, El-Serag HB, Smout AJ, et al. Symptomatic reflux disease: The present, the past and the future[J]. Gut. 2014,63(7):1185-1193.
[7] Asanuma K, Iijima K, Shimosegawa T. Gender difference in gastro-esophageal reflux diseases[J]. World J Gastroenterol, 2016,22(5):1800-1810.
[8] Iijima K, Shimosegawa T. Involvement of luminal nitric oxide in the pathogenesis of the gastroesophageal reflux disease spectrum[J]. J Gastroenterol Hepatol, 2014,29(5):898-905.
[9] Masaka T, Iijima K, Endo H, et al. Gender differences in oesophageal mucosal injury in a reflux oesophagitis model of rats[J]. Gut, 2013,62(1):6-14.
[10] Nordenstedt H, Zheng Z, Cameron AJ, et al. Postmenopausal hormone therapy as a risk factor for gastroesophageal reflux symptoms among female twins[J]. Gastroenterology, 2008,134(4):921-928.
[11] Jacobson BC, Moy B, Colditz GA, et al. Postmenopausal hormone use and symptoms of gastroesophageal reflux[J]. Arch Intern Med, 2008,168(16):1798-1804.
[12] 贺宇彤, 李道娟, 梁迪, 等. 2013年中国食管癌发病和死亡估计[J]. 中华肿瘤杂志, 2017,39(4):315-320.
[13] Mathieu LN, Kanarek NF, Tsai HL, et al. Age and sex differences in the incidence of esophageal adenocarcinoma: Results from the surveillance, epidemiology, and end results (SEER) registry (1973-2008)[J].Dis Esophagus, 2014,27(8):757-763.
[14] Wang BJ, Zhang B, Yan SS, et al. Hormonal and reproductive factors and risk of esophageal cancer in women: A meta-analysis[J]. Dis Esophagus, 2016,29(5):448-454.
[15] Wang QM, Qi YJ, Jiang Q, et al. Relevance of serum estradiol and estrogen receptor beta expression from a high-incidence area for esophageal squamous cell carcinoma in China[J]. Med Oncol, 2011,28(1):188-193.
[16] Zhang Z, He Q, Fu S, Zheng Z. Estrogen receptors in regulating cell proliferation of esophageal squamous cell carcinoma: Involvement of intracellular Ca2+signaling[J]. Pathol Oncol Res, 2017,23:329-334.
[17] Zuguchi M, Miki Y, Onodera Y, et al. Estrogen receptor α and β in esophageal squamous cell carcinoma[J]. Cancer Sci, 2012,103(7):1348-1355.
[18] Zhang D, Ku J, Yi Y, et al. The prognostic values of estrogen receptor alpha and beta in patients with gastroesophageal cancer: A meta-analysis[J]. Medicine, 2019,98(46):e.
[19] Kurt D, Saruhan BG, Kanay Z, et al. Effect of ovariectomy and female sex hormones administration upon gastric ulceration induced by cold and immobility restraint stress[J].Saudi Med J, 2007,28(7):1021-1027.
[20] Zhou J, Teng R, Xu C, Wang Q, et al. Overexpression of ERα inhibits proliferation and invasion of MKN28 gastric cancer cells by suppressing β-catenin[J]. Oncol Rep, 2013,30(4):1622-1630.
[21] Tang W, Liu R, Yan Y, et al. Expression of estrogen receptors and androgen receptor and their clinical significance in gastric cancer[J]. Oncotarget, 2017,8(25):-.
[22] Zhang Y, Wu Y, Zhou X, et al. Estrogen Receptor Beta Inhibits The Proliferation, Migration, And Angiogenesis Of Gastric Cancer Cells Through Inhibiting Nuclear Factor-Kappa B Signaling[J]. Onco Targets Ther, 2019,12(11):9153-9164.
[23] Jacenik D, Cygankiewicz AI, Fichna J, et al. Estrogen signaling deregulation related with local immune response modulation in irritable bowel syndrome[J]. Mol Cell Endocrinol, 2018,471:89-96.
[24] Qin B, Dong L, Guo X, et al. Expression of G protein-coupled estrogen receptor in irritable bowel syndrome and its clinical significance[J]. Int J Clin Exp Pathol, 2014,7(5):2238-2246.
文章来源:《胃肠病学和肝病学杂志》 网址: http://www.wcbxhgbxzz.cn/qikandaodu/2021/0104/389.html
上一篇:胃肠疾病常见6症状
下一篇:荆花胃康胶丸临床治疗胃肠病患者真实世界病例